Pasar al contenido principal

MATEMATICA APLICADA A LA ONCOHEMATOLOGIA PEDIATRICA

PID2022-140451OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CADIZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia

  • Martínez Rubio, Álvaro
  • Chulian García, Salvador
  • Niño López, Ana del Rosario
  • Picón González, Rocío
  • Rodríguez Gutiérrez, Juan Francisco
  • Gálvez de la Villa, Eva
  • Caballero-Velázquez, Teresa
  • Molinos Quintana, Águeda
  • Castillo Robleda, Ana
  • Ramírez Orellana, Manuel
  • Martínez-Sánchez, María V.
  • Minguela Puras, Alfredo
  • Fuster Soler, José Luis
  • Blázquez Goñi, Cristina
  • Pérez-García, Víctor M.
  • Rosa Durán, María
B-cell Acute Lymphoblastic Leukemia is the most prevalent form of childhood cancer, with approximately 15% of patients undergoing relapse after initial treatment. Further advancements depend on novel therapies and more precise risk stratification criteria. In the context of computational flow cytometry and machine learning, this paper aims to explore the potential prognostic value of flow cytometry data at diagnosis, a relatively unexplored direction for relapse prediction in this disease. To this end, we collected a dataset of 252 patients from three hospitals and implemented a comprehensive pipeline for multicenter data integration, feature extraction, and patient classification, comparing the results with existing algorithms from the literature. The analysis revealed no significant differences in immunophenotypic patterns between relapse and non-relapse patients and suggests the need for alternative approaches to handle flow cytometry data in relapse prediction.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Understanding the role of B cells in CAR T-cell therapy in leukemia through a mathematical model

  • Serrano, Sergio
  • Barrio, Roberto
  • Martínez Rubio, Álvaro
  • Belmonte Beitia, Juan
  • Pérez-García, Víctor M.
Chimeric Antigen Receptor T (CAR-T) cell therapy has been proven to be successful against different leukaemias and lymphomas. This paper makes an analytical and numerical study of a mathematical model describing the competition of CAR-T, leukaemias tumor and B cells. Considering its significance in sustaining anti-CD19 CAR T-cell stimulation, we integrate a B-cell source term into the model. Through stability and bifurcation analyses, we reveal the potential for tumor eradication contingent on the continuous influx of B-cells, uncovering a transcritical bifurcation at a critical B-cell input. Additionally, we identify an almost heteroclinic cycle between equilibrium points, providing a theoretical basis for understanding disease relapse. Analyzing the oscillatory behavior of the system, we approximate the time-dependent dynamics of CAR T-cells and leukemic cells, shedding light on the impact of initial tumor burden on therapeutic outcomes. In conclusion, our study provides insights into CAR T-cell therapy dynamics for acute lymphoblastic leukemias, offering a theoretical foundation for clinical observations and suggesting avenues for future immunotherapy modeling research.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia

  • Martínez-Rubio, Álvaro
  • Chulián, Salvador
  • Niño-López, Ana
  • Picón-González, Rocío
  • Rodríguez Gutiérrez, Juan F.
  • Gálvez de la Villa, Eva
  • Caballero Velázquez, Teresa
  • Molinos-Quintana, A.
  • Castillo-Robleda, Ana
  • Ramírez Orellana, Manuel
  • Martínez Sánchez, María Victoria
  • Minguela Puras, Alfredo
  • Fuster Soler, José Luis
  • Blázquez Goñi, Cristina
  • Pérez-García, Víctor M.
  • Rosa, María
B-cell Acute Lymphoblastic Leukemia is the most prevalent form of childhood cancer, with approximately 15% of patients undergoing relapse after initial treatment. Further advancements depend on novel therapies and more precise risk stratification criteria. In the context of computational flow cytometry and machine learning, this paper aims to explore the potential prognostic value of flow cytometry data at diagnosis, a relatively unexplored direction for relapse prediction in this disease. To this end, we collected a dataset of 252 patients from three hospitals and implemented a comprehensive pipeline for multicenter data integration, feature extraction, and patient classification, comparing the results with existing algorithms from the literature. The analysis revealed no significant differences in immunophenotypic patterns between relapse and non-relapse patients and suggests the need for alternative approaches to handle flow cytometry data in relapse prediction., This work was partially supported by project PDC2022-133520-I00 funded by Ministerio de Ciencia e Innovación/ Agencia Estatal de investigación (doi:10.13039/501100011033) and European Union NextGenerationEU/PRTR; by project PID2022-140451OA-I00 funded by Ministerio de Ciencia e Innovación/Agencia Estatal de investigación (doi:10.13039/501100011033) and ERDF A way of making Europe; and by University of Castilla-La Mancha/ERDF, A way of making Europe (Applied Research Projects) under grant 2022-GRIN-34405. The support of Fundación Española para la Ciencia y la Tecnología (FECYT project PR214), Asociación Pablo Ugarte (APU, Spain) and Junta de Andalucía (Spain) group FQM-201 is also acknowledged. This work was also subsidized in its early stages by a grant for the research and biomedical innovation in the health sciences within the framework of the Integrated Territorial Initiative (ITI) for the province of Cádiz (grant number ITI-0038-2019)., Peer reviewed